[Corrigendum to: "Drug approval: Zanubrutinib in monotherapy for chronic lymphocytic leukemia" [Bull Cancer 2023;110:739-745]]
- PMID: 38182437
- DOI: 10.1016/j.bulcan.2023.12.001
[Corrigendum to: "Drug approval: Zanubrutinib in monotherapy for chronic lymphocytic leukemia" [Bull Cancer 2023;110:739-745]]
Erratum for
-
[New drug approval: Zanubrutinib in monotherapy for chronic lymphocytic leukemia].Bull Cancer. 2023 Jul-Aug;110(7-8):744-745. doi: 10.1016/j.bulcan.2023.03.020. Epub 2023 Apr 19. Bull Cancer. 2023. PMID: 37085342 French. No abstract available.
Publication types
LinkOut - more resources
Full Text Sources
